The field of interventional cardiology for congenital heart disease has experienced considerable progress in the last few years. Transcatheter closure of congenital heart defect is now a well-established procedure, but potential dangers of a foreign object in the body are still concerned. Bioabsorbable device aiming at leaving little or no foreign material behind remains promising alternatives for the future. Percutaneous valve replacement has received tremendous interest as a direct result of advancement in endovascular techniques. With further development and improvement, this technique is expected to be used routinely in clinical practice. The "hybrid" approach, a novel strategy to congenital heart disease, allows surgeons and interventional cardiologists to combine their expertise and provide the best approach to correct or palliate these defects with optimal outcomes. This concept may enable new treatment options, especially in patients with complex congenital heart defects.